LifeVantage (NASDAQ:LFVN) Posts Quarterly Earnings Results, Beats Estimates By $0.08 EPS

LifeVantage (NASDAQ:LFVNGet Free Report) released its quarterly earnings data on Wednesday. The company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.08, Zacks reports. LifeVantage had a net margin of 2.11% and a return on equity of 29.24%.

LifeVantage Stock Performance

Shares of LFVN traded down $2.73 during trading hours on Thursday, reaching $20.02. 692,144 shares of the company traded hands, compared to its average volume of 287,299. LifeVantage has a 1-year low of $5.22 and a 1-year high of $27.38. The stock has a market cap of $250.69 million, a P/E ratio of 62.33 and a beta of 0.84. The stock’s fifty day moving average is $18.97 and its 200 day moving average is $13.59.

LifeVantage Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Monday, March 3rd will be issued a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.80%. LifeVantage’s dividend payout ratio (DPR) is presently 28.57%.

Analyst Ratings Changes

Several analysts have issued reports on LFVN shares. Craig Hallum initiated coverage on LifeVantage in a report on Tuesday, January 14th. They set a “buy” rating and a $35.00 price objective on the stock. Lake Street Capital initiated coverage on LifeVantage in a research report on Thursday, December 19th. They set a “buy” rating and a $26.00 price target on the stock.

View Our Latest Stock Analysis on LifeVantage

About LifeVantage

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Further Reading

Earnings History for LifeVantage (NASDAQ:LFVN)

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.